Leyre Silva

Pamplona, NC, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications

Immunogenicity of neoantigens from hepatocellular carcinoma patients treated with a combined radioimmunotherapy.

Immunogenicity of neoantigens from hepatocellular carcinoma patients treated with a combined radioimmunotherapy.

Journal: Oncoimmunology
Published: March 19, 2026

MERTK inhibition improves therapeutic efficacy of immune checkpoint inhibitors in hepatocellular carcinoma.

MERTK inhibition improves therapeutic efficacy of immune checkpoint inhibitors in hepatocellular carcinoma.

Journal: Oncoimmunology
Published: March 03, 2025

Erratum: Enhanced cross-recognition of SARS-CoV-2 Omicron variant by peptide vaccine-induced antibodies.

Erratum: Enhanced cross-recognition of SARS-CoV-2 Omicron variant by peptide vaccine-induced antibodies.

Journal: Frontiers in immunology
Published: February 23, 2023

Enhanced cross-recognition of SARS-CoV-2 Omicron variant by peptide vaccine-induced antibodies.

Enhanced cross-recognition of SARS-CoV-2 Omicron variant by peptide vaccine-induced antibodies.

Journal: Frontiers in immunology
Published: September 14, 2022

Gemcitabine-mediated depletion of immunosuppressive dendritic cells enhances the efficacy of therapeutic vaccination.

Gemcitabine-mediated depletion of immunosuppressive dendritic cells enhances the efficacy of therapeutic vaccination.

Journal: Frontiers in immunology
Published: July 11, 2022

Identification of HLA class I-restricted immunogenic neoantigens in triple negative breast cancer.

Identification of HLA class I-restricted immunogenic neoantigens in triple negative breast cancer.

Journal: Frontiers in immunology
Published: July 04, 2022

Neoantigens as potential vaccines in hepatocellular carcinoma.

Neoantigens as potential vaccines in hepatocellular carcinoma.

Journal: Journal for immunotherapy of cancer
Published: January 26, 2022

Cold-Inducible RNA Binding Protein as a Vaccination Platform to Enhance Immunotherapeutic Responses Against Hepatocellular Carcinoma.

Cold-Inducible RNA Binding Protein as a Vaccination Platform to Enhance Immunotherapeutic Responses Against Hepatocellular Carcinoma.

Journal: Cancers
Published: October 09, 2020

Inhibition of adjuvant-induced TAM receptors potentiates cancer vaccine immunogenicity and therapeutic efficacy.

Inhibition of adjuvant-induced TAM receptors potentiates cancer vaccine immunogenicity and therapeutic efficacy.

Journal: Cancer letters
Published: July 22, 2020

Enhancement of Antitumor Vaccination by Targeting Dendritic Cell-Related IL-10.

Enhancement of Antitumor Vaccination by Targeting Dendritic Cell-Related IL-10.

Journal: Frontiers in immunology
Published: June 28, 2018

Enhanced anti-tumor efficacy of checkpoint inhibitors in combination with the histone deacetylase inhibitor Belinostat in a murine hepatocellular carcinoma model.

Enhanced anti-tumor efficacy of checkpoint inhibitors in combination with the histone deacetylase inhibitor Belinostat in a murine hepatocellular carcinoma model.

Journal: Cancer immunology, immunotherapy : CII
Published: January 17, 2018

The Toll like receptor 4 ligand cold-inducible RNA-binding protein as vaccination platform against cancer.

The Toll like receptor 4 ligand cold-inducible RNA-binding protein as vaccination platform against cancer.

Journal: Oncoimmunology
Published: June 16, 2017
Showing 1-12 of 16

Last Updated: 09/26/2026